[CH3:1][CH2:2][CH2:3][CH2:4][C:5]([N:7]([C@H:26]([C:30]([OH:32])=[O:31])[CH:27]([CH3:29])[CH3:28])[CH2:8][C:9]1[CH:10]=[CH:11][C:12]([C:15]2[CH:16]=[CH:17][CH:18]=[CH:19][C:20]=2[C:21]2[NH:22][N:23]=[N:24][N:25]=2)=[CH:13][CH:14]=1)=[O:6].[Ba].Cl>C(OCC)(=O)C.O>[C:30]([C@@H:26]([N:7]([C:5](=[O:6])[CH2:4][CH2:3][CH2:2][CH3:1])[CH2:8][C:9]1[CH:10]=[CH:11][C:12]([C:15]2[CH:16]=[CH:17][CH:18]=[CH:19][C:20]=2[C:21]2[NH:22][N:23]=[N:24][N:25]=2)=[CH:13][CH:14]=1)[CH:27]([CH3:28])[CH3:29])([OH:32])=[O:31]A slurry of valsartan barium (90 g) in ethyl acetate (900 ml) and water (360 ml) was treated with hydrochloric acid to attain a pH of about 2 to 2.5. The organic layer was separated, washed with water (3×270 ml) and concentrated at about 45° to 50° C. under reduced pressure. The residue was dissolved in ethyl acetate (225 ml) at 45° to 50° C., filtered at hot condition and cooled to 20° to 25° C. Pentane (900 ml) was then added slowly to the mixture and stirred for 1 hour at 20° to 25° C. The solid obtained was filtered, washed with pentane (2×90 ml) and dried under reduced pressure to obtain the title compound.